Prions, new molecular forms of biological information

Research in Immunology

Volumn 149, Issue 7-8, 1998, Pages 711-717

  Dormont, D ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

Creutzfeldt Jakob disease; Spongiform encephalopathies; Prion; Review

Indexed keywords

BRAIN SPONGIOSIS; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; HUMAN; MOLECULAR MODEL; PATHOGENESIS; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0032323995     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(99)80044-3     Document Type: Conference Paper

References (64)

1. Adjou, K.T., Demaimay, R., Lasmézas, C., Deslys, J.P. & Seman, M. (1995), MS-8209, a new amphotericin B derivative provides enhanced efficacy in delaying hamster scrapie. Antimicrob. Agents Chemother., 39, 2810-2812.
2. Adjou, K.T., Demaimay, R., Lasmézas, C.I., Seman, M., Deslys, J.P. & Dormont, D. (1996). Differential effects of a new amphotericin B derivative, MS-8209, on mouse BSE and scrapie: implications for the mechanism of action of polyene antibiotics. Res. Virol., 147, 213-218.
3. Alperovitch, A., Brown, P., Weber, T., Pocchiari, M., Hofman, A. & Will, R. (1994), Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet, 343, 918.
4. Baker, H.F., Ridley, R.M. & Wells, G.A.H. (1993), Experimental transmission of BSE and scrapie to the common marmoset. Vet. Rec., 132, 403-406.
5. Blättler, T., Brandner, S., Raeber, A., Klein, M.A., Volgtländer, T., Weissmann, C. & Aguzzi, A. (1997), PrP-expressing tissue required for transfer of scrapie infectvity from spleen to brain. Nature, 389, 69-73.
6. Bolton, D.C. & Bendheim, P.E. (1988), A modified host protein model of scrapie, in C. F. Symposium. Novel infectious agents and the central nervous system. John Wiley & Sons, 135, 164-177.
7. Brandner, S., Isemann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C. & Aguzzi, A. (1996), Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature, 379, 339-343.
8. Brown, P., Preece, M.A. & Will, R.G. (1992), Friendly fire in medicine - hormones, homografts, and Creutzfeldt-Jakob disease. Lancet, 340, 24-27.
9. Brown, P., Rohwer, R.G. & Gajdusek, D.C. (1986), Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J. Inf. Dis., 153, 1145-1148.
10. Brown, P., Rohwer, R.G., Green, E.M. & Gajdusek, D.C. (1983a), The effect of chemicals, heat, and histopathologic processing on high infectivity hamster-adapted scrapie virus. Virus non conventionnels et affections du système nerveux central. L. Court. Paris. Masson: pp. 156-163.
11. Brown, P., Rowher, R.G., Green, E.M. & Gajdusek, D.C. (1983b), The effects of chemicals, heat, and histopathologic processing on high-infectivity hamster adapted scrapie virus. Virus non conventionnels et affections du système nerveux central. L. A. Court. Paris. Masson: pp. 156-163.
12. Bruce, M., Chree, A., McConnell, I., Foster, J., Pearson, G. & Fraser, H. (1994a), Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos. Trans. R. Soc. Lond. [Biol], 343, 405-411.
13. Bruce, M., Chree, A., McConnell, I., Foster, J., Pearson, G. & Fraser, H. (1994b), Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Phil. Trans. R. Soc. Lond., 343, 405-411.
14. Bruce, M.E. (1996), Strain typing studies of scrapie and BSE, in "Prion diseases" (H. Baker & R. M. Ridley) (pp. 223-236). Humana Press Inc, Totowa, NJ.
15. Bruce, M.E., Chree, A., McConnell, I., Foster, J., Pearson, G. & Fraser, H. (1993), Agent strain variation in BSE and scrapie. Scientific Veterinary Committee of the Commission of the European Communities. 14-15 September. Proceedings of a consultation on BSE.
16. Bruce, M.E., McConnell, I., Fraser, H. & Dickinson, A.G. (1991), The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J. Gen. Virol., 72, 595-603.
17. Bruce, M.E., Will, R.G., Ironside, J.W., McConnell, I., Drummond, D., Suttie, A., McCardle, L., Chree, A., Hope, J., Birkett, C., Cousens, S., Fraser, H. & Bostock, C.J. (1997), Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature, 389, 498-501.
18. Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.A., Autenried, P., Aguet, M. & Weissmann, C. (1993), Mice devoid of PrP are resistant to scrapie. Cell, 73, 1339-1347.
19. Carp, R.I. & Callahan, S.M. (1982), Effect of mouse peritoneal macrophages on scrapie infectivity during extended in vitro incubation. Intervirology, 17, 201-207.
20. Chazot, G., Broussole, E., Blattier, T., Aguzzi, A. & Kopp, N. (1996), New variant of Creutzfeldt-Jakob disease in a 26-year old french man. Lancet, 347, 1181.
21. Clarke, M.C. & Kimberlin, R.H. (1984), Pathogenesis of mouse scrapie: distribution of agent in the pulp and stroma of infected spleens. Vet. Microbiol., 9, 215-225.
22. Cohen, F.E., Pan, K.M., Huang, Z., Baldwin, M., Fletterick, R.J. & Prusiner, S.B. (1994), Structural clues to prion replication. Science, 264, 530-531.
23. Collinge, J., Sidle, K.C.L., Meads, J., Ironside, J. & Hill, A.F. (1996), Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature, 383, 685-690.
24. Demaimay, R., Adjou, K.T., Beringue, V., Demart, S., Lasmézas, C., Deslys, J.P., Seman, M. & Dormont, D. (1997), Late treatment with polyeneantibiotics can prolong the survival time of scrapie-infected animals. J. Virol., 71, 9685-9689.
25. Demaimay, R., Adjou, K.T., Lasmézas, C.I., Lazarini, F., Cherifi, K., Deslys & J.P., Dormont, D. (1994), Pharmacological studies of a new derivative of Amphotericin-B, MS-8209, in mouse and hamster scrapie. J. Gen. Virol., 75, 2499-2503.
26. Deslys, J.P., Lasmézas, C., Streichenberger, N., Hill, A., Collinge, J., Dormont, D. & Kopp, N. (1997), New variant Creutzfeldt-Jakob disease in France. Lancet, 349, 30-31.
27. Dickinson, A.G., Bruce, M.E., Outram, G.W. & Kimberlin, R.H. (1984), Scrapie strain differences: the implications of stability and mutation, in "Proceedings of workshop on slow transmissible diseases (Japanese)". (J. Tateishi. Tokyo. Tateishi, J.) (pp. 105-118).
28. Dickinson, A.G. & Taylor, D.M. (1978), Resistance of scrapie to decontamination. New Eng. J. Med., 299, 1413-1414.
29. Eklund, C.M., Kennedy, R.C. & Hadlow, W.J. (1967), Pathogenesis of scrapie virus infection in the mouse. J. Infect. Dis., 117, 15-22.
30. Ernst, D.R. & Race, R.E. (1993), Comparative Analysis of Scrapie Agent Inactivation Methods. J. Virol. Methods, 41, 193-201.
31. Fraser, H. & Dickinson, A.G. (1978), Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J. Comp. Pathol., 88, 563-573.
32. Fraser, H., Farquhar, C.F., McConnell, I. & Davies, D. (1989), The scrapie disease process is unaffected by ionising radiation, in "Alzheimer's disease and related disorders". Alan R. Liss, Inc., pp. 653-658.
33. Haig, D.A. & Clark, M.C. (1968), The effect of β propiolactone on the scrapie agent. J. Gen. Virol., 3, 281-283.
34. Hill, A.F., Zeldler, M., Ironside, J. & Collinge, J. (1997), Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet, 349, 99-100.
35. Hope, J. & Baybutt, H. (1991), The key role of the nerve membrane protein PrP in scrapie-like diseases. Sem. Neurosci., 3, 165-171.
36. Kimberlin, R.H. & Walker, C.A. (1979), Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol., 89, 551-562.
37. Kimberlin, R.H. & Walker, C.A. (1978), Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. J. Comp. Pathol., 88, 39-47.
38. Kimberlin, R.H. & Walker, C.A. (1989), Pathogenesis of scrapie in mice after intra-gastric infection. Virus Res., 12, 213-200.
39. Kitamoto, T., Muramoto, T., Mohri, S., Doh-Ura, K. & Tateishi, J. (1991), Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol., 65, 6292-6295.
40. Klein, M.A., Frigg, R., Fleschsig, E., Raeber, A.J., Kalinke, U., Bluethmann, H., Bootz, F., Suter, M., Zinkemagel, R.M. & Aguzzi, A. (1997), A crucial role for B cells in neuroinvasive scrapie. Nature, 390, 687-690.
41. Lasmézas, C., Cesbron, J.Y., Deslys, J.P., Demaimay, R., Adjou, K.T., Rioux, R., Lemaire, C., Locht, C. & Dormont, D. (1996a), Immune system-dependent and -independent replication of the scrapie agent. J. Virol., 70, 1292-1295.
42. Lasmézas, C.I., Deslys, J.P., Robain, O., Demaimay, R., Adjou, K.T., Lamoury, F., Ironside, J., Hauw, J.J. & Dormont, D. (1996b), BSE transmission to macaques. Nature, 381, 743-744.
43. Latarget, R., Muel, B., Haig, D.A., Clarke, M.C. & Alper, T. (1970), Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature, 227, 1341-1343.
44. Latarjet, R. (1979), Inactivation of the agents of scrapie, Creutzfeldt-Jakob disease, and kuru by radiations, in "Slow transmissible diseases of the nervous system". (S.B. Prusiner & W.J. Hadlow) (pp. 387-408).Academic Press.
45. McBride, P.A., Eikelenboom, P., Kraal, G., Fraser, H. & Bruce, M.E. (1992), PrP Protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J. Pathol., 168, 413-418.
46. Mckinley, M.P., Masiarz, F.R., Isaacs, S.T., Hearst, J.E. & Prusiner, S.B. (1983), Resistance of the scrapie agent to inactivation by psoralens. Photochem. Photobiol., 37, 539-545.
47. Mertz, P.A., Rubenstein, R., Carp, R.I. & Laszack, R.J. (1989), Evidence to implicate SAF as a form of the infectious agent, in "Unconventional diseases of the central nervous system". (L. A. Court, D. Dormont, P. Brown & D. T. Kingsbury) (pp. 478-488). CEA-Diffusion.
48. Merz, P.A., Somerville, R.A., Wisniewski, H.M. & Iqbal, K. (1981), Abnormal fibrils from scrapie-infected brain. Acta Neuropathol., 54, 63-74.
49. Oesch, B., Westaway, D. & Prusiner, S.B. (1991), Prion protein genes: evolutionary and functional aspects, in "Current topics in microbiology and immunology, transmissible spongiform encephalopathies: scrapie, BSE and related disorders". (B. W. Chesebro) (pp. 109-124). Springer-Verlag.
50. Oesch, B., Westaway, D., Walchli, M., Mckinley, M.P., Kent, S.B., Aebersold, R., Barry, R.A., Tempst, P., Teplow, D.B., Hood, L.E., Prusiner, S.B. & Weissmann, C. (1985), A cellular gene encodes scrapie PrP 27-30 protein. Cell, 40, 735-746.
51. Prusiner, S.B. (1982), Novel proteinaceous infectious particles cause scrapie. Science, 216, 136-144.
52. Prusiner, S.B. (1993), Transgenetic investigations of prion diseases of humans and animals. Philos. Trans. R. Soc. Lond. [Biol], 339, 239-254.
53. Prusiner, S.B., Füzi, M., Scott, M., Serban, D., Serban, H., Taraboulos, A., Gabriel, J.M., Wells, G.A.H., Wilesmith, J.W., Bradley, R., DeArmond, S.J. & Kristensson, K. (1993), Immunologic and molecular biologic studies of prion proteins in bovine spongiform encephalopathy. J. Infect. Dis., 167, 602-613.
54. Prusiner, S.B., Gabizon, R. & Mckinley, M. P. (1987), On the biology of prions. Acta neuropathol. (Berl), 72, 299-314.
55. Prusiner, S.B., Groth, D.F., Cochran, S.P., Masiarz, F.R., Mckinley, M.P. & Martinez, H.M. (1980), Molecular properties, partial purifications, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry, 19, 4883-4891.
56. Prusiner, S.B., McKinley, M.P., Bowman, K.A., Bolton, D.C., Bendheim, P.E., Groth, D.F. & Glenner, G.G. (1983), Scrapie prions aggregate to form amyloid-like birefringent rods. Cell, 35, 349-358.
57. Prusiner, S.B., McKinley, M.P., Groth, D.F., Bowman, K.A., Mock, N.I., Cochran, S.P. & Masiarz, F.R. (1981), Scrapie agent contains a hydrophobic protein. Proc. Natl. Acad. Sci. USA, 78, 6675-6679.
58. Prusiner, S.B., Scott, M., Foster, D., Pan, K.M., Groth, D., Mirenda, C., Torchia, M., Yang, S.L., Serban, D., Carlson, G.A., Hoppe, P.C., Westaway, D. & DeArmond, S.J. (1990), Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell, 63, 673-686.
59. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R. & Wüthrich, K. (1996), NMR structure of the mouse prion protein domain PrP (121-231). Nature, 382, 180-182.
60. Riek, R., Hornemann, S., Wider, G., Glockshuber, R. & Wüthrich, K. (1997), NMR characterization of the full-length recombinant murine prion protein mPrP(23-231). FEBS Lett., 413, 282-288.
61. Taylor, D.M. & McConnell, I. (1988), Autoclaving does not decontaminate formol-fixed scrapie tissues. Lancet, 1, 1463-1464.
62. Telling, G.C., Scott, M., Mastriani, J., Gabizon, R., Torchia, M., Cohen, F.E., DeArmond, S.J. & Prusiner, S.B. (1995), Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell, 83, 79-90.
63. Will, R.G., Ironside, J.W., Zeidler, M., Cousens, S.N., Estibeiro, K., Alpérovitch, A., Poser, S., Hofman, A. & Smith, P.G. (1996), A new -variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921-925.
64. Xi, Y.G., Ingrosso, L., Ladogana, A., Masullo, C. & Pocchiari, M. (1992), Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature, 356, 598-601.